Christopher D Riemann MD
Retinal Disease
Member, Board of Directors - Cincinnati Eye Institute Director, Vitreoretinal Fellowship - Cincinnati Eye Institute and University of Cincinnati Section Head Ophthalmology, Bethesda North Hospital
Join to View Full Profile
1945 Cei DriveCincinnati, OH 45242
Phone+1 513-984-5133
Fax+1 513-569-3941
Dr. Riemann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Ophthalmology, 1995 - 1998
York HospitalInternship, Transitional Year, 1994 - 1995
University of Maryland School of MedicineClass of 1994
Certifications & Licensure
KY State Medical License 1999 - 2026
OH State Medical License 1995 - 2026
PA State Medical License 1994 - 1995
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Treatment for Presumed Ocular Histoplasmosis Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Postoperative Methotrexate to Reduce Reoperation Rate and Improve Vision in Patients With Complex Retinal Detachments, Advanced Diabetic Retinopathy, and Trauma.Lauren Gibson, Alyson Nguyen, Jared Ridgeway, Mariam Omar, Christopher Purvis
Journal of Vitreoretinal Diseases. 2025-03-18 - Intraocular use of methotrexate (MTX) for the treatment of proliferative vitreoretinopathy (PVR) in congenital aniridia (CI) and a possible link to aniridia fibrosis s...Naveen R Ambati, Christopher D Riemann
American Journal of Ophthalmology Case Reports. 2024-12-01 - Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics.Eric W Schneider, Jeffrey S Heier, Nancy M Holekamp, Miguel A Busquets, Alan L Wagner
Ophthalmology Science. 2024-11-26
Press Mentions
Ergonomics: Care for Yourself to Improve Patient CareAugust 31st, 2022- Paladin Phase 4 Study Confirms Safety of Durable ILUVIEN® Treatment and Reduces Burden of Care for DME PatientsJuly 26th, 2022
- Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.September 13th, 2021
- Join now to see all
Professional Memberships
- Fellow
External Links
- CEIhttp://www.cincinnatieye.com/doctors/christopher-d-riemann-m-d/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
